CN114249690A - Synthesis method of Rosxastat - Google Patents

Synthesis method of Rosxastat Download PDF

Info

Publication number
CN114249690A
CN114249690A CN202010994236.7A CN202010994236A CN114249690A CN 114249690 A CN114249690 A CN 114249690A CN 202010994236 A CN202010994236 A CN 202010994236A CN 114249690 A CN114249690 A CN 114249690A
Authority
CN
China
Prior art keywords
reaction
dbu
crude product
process according
synthesis method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010994236.7A
Other languages
Chinese (zh)
Inventor
朱信猛
韩瑞燕
李春雷
王克艳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Wanbang Biopharmaceutical Group Co ltd
Original Assignee
Jiangsu Wanbang Biopharmaceutical Group Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Wanbang Biopharmaceutical Group Co ltd filed Critical Jiangsu Wanbang Biopharmaceutical Group Co ltd
Priority to CN202010994236.7A priority Critical patent/CN114249690A/en
Publication of CN114249690A publication Critical patent/CN114249690A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a synthesis method of roxasistat, wherein a compound (I) takes 1, 8-diazabicycloundecen-7-ene (DBU) as alkali and toluene as a reaction solvent to react with glycine; and after the reaction is finished, cooling, adding water, separating liquid, washing, adjusting acid, pulping, filtering and drying to obtain the crude product (II) of the target product of the roxasistat. The reaction of the present invention is modified with a liquid organic base DBU and preferably with a molar equivalent; toluene is used as a reaction solvent, and the solvent amount is optimized; the reaction temperature is reduced and the reaction time is shortened through the improvement. Meanwhile, the post-treatment is simplified, and the liquid is directly separated without being concentrated under reduced pressure.

Description

Synthesis method of Rosxastat
Technical Field
The invention belongs to the technical field of synthesis of raw material medicines and intermediates, and particularly relates to a method for synthesizing crude product of rosmarinic acid.
Background
In the past, the quality is firstly focused on from the perspective of raw medicines, but under the current policy of purchasing the 4+7 belt quantity of the imitation drugs, the quality is not enough, and whether the synthesis process of the raw medicines is suitable for industrial scale-up production is focused on. Aiming at the step of the condensation reaction of the urethane in the synthesis process of the roxasistat, the analysis of the existing main synthesis method is as follows:
on the one hand, the polyurethane condensation reaction is completed under an organic base/methanol system, and the reaction is carried out overnight at 100-110 ℃ (CN108794397, WO2014114834 and CN108341777), and the yield is 65-86%. The method requires higher reaction temperature, and the solvent methanol is selected, and the conventional condition cannot reach the temperature. Therefore, special pressure equipment (such as a stainless steel muzzle) must be used, which increases the difficulty and danger of industrial scale-up production. The reaction conditions are harsh, the amplification production is not facilitated, and the yield is not high
On the other hand, the reaction solvent is changed to a high boiling point solvent such as 1, 4-dioxane, ethylene glycol monomethyl ether and the like to remove the special pressure equipment. However, the solubility of the solvents to sodium methoxide is poor, and the reaction effect is poor; and the concentration temperature requirement is higher during the post-treatment reduced pressure concentration, the concentration time is longer, and the ether solvent is risky to concentrate at high temperature, which also increases the cost and the risk of industrial production and is not suitable for industrial amplification.
In addition, the process of patent CN 104024227A requires too long steps to obtain the target product (3 steps from compound 7 to compound 10), and the patent uses dangerous reagents such as borane.
Disclosure of Invention
In combination with the technical problems in the prior art, the method provided by the invention can complete the reaction at a lower reaction temperature, and improve the reaction yield. And no special equipment requirement exists, the post-treatment is simple and feasible, the production cost is saved, and the method is suitable for industrial amplification.
The invention provides a synthesis method of crude product of roxasistat, which has the chemical reaction formula:
Figure BDA0002691950990000011
the compound (I) takes 1, 8-diazabicycloundecen-7-ene (DBU) as alkali and toluene as reaction solvent to react with glycine, thus obtaining the target product of crude product of the roxasistat (II).
Further, the DBU of the present invention is used in a molar amount of 2.0 to 5.0 times, preferably 3.0 times, the compound (I). If it is lower than this range, the reaction cannot proceed, and if it is higher than this range, the post-treatment is difficult.
Further, the molar ratio of DBU and glycine in the reaction of the DBU and the glycine is as follows: (0.8-1.2): 1, preferably 1: 1.
The reaction solvent is toluene, and the toluene is selected as the solvent, so that the post-treatment is simpler, special pressure equipment is avoided, and the industrialization cost and the risk are effectively reduced.
Furthermore, the amount of the reaction solvent used in the present invention is 4 to 7ml/g of the compound (I), preferably 6ml/g of the compound (I).
Furthermore, the reaction temperature used in the invention is 25-100 ℃, preferably 80-85 ℃.
Furthermore, the reaction time is 1-5 hours, preferably 3 hours.
In some embodiments, the reaction of the present invention is completed with a post-treatment step, and in a specific embodiment, the post-treatment step is specifically: after the reaction is finished, the crude product (II) of the target product, namely the roxasistat, is obtained through cooling, water adding, liquid separation, washing, acid adjustment, pulping, filtering and drying.
Further, after the reaction is finished, cooling to 35-40 ℃, adding water for dissolving, separating liquid, and washing the water phase with ethyl acetate for 1-3 times.
Further, the pH of the water phase is adjusted to 3.8-4.2, preferably 4 by glacial acetic acid.
Further, adjusting acid to separate out solid, pulping at room temperature for 1.5-2.5 h h, filtering, washing a filter cake with purified water until the pH value is 5.8-6.2, and vacuum-drying at 55-60 ℃ for more than 12h to obtain a crude product of the roxasistat.
In summary, the method of the present invention is improved mainly from the following aspects: 1) the reaction is modified with a liquid organic base DBU and preferably with a molar equivalent; 2) toluene is used as a reaction solvent, and the solvent amount is optimized; 3) the reaction temperature is reduced and the reaction time is shortened by the improvement of the first two points. Meanwhile, the post-treatment is simplified, and the liquid is directly separated without being concentrated under reduced pressure.
Detailed Description
The following examples are given to facilitate a better understanding of the invention, but do not limit the invention. The experimental procedures in the following examples are conventional unless otherwise specified. The test materials used in the following examples were purchased from a conventional biochemical reagent store unless otherwise specified.
Example 1
Preparation of the crude product (II) of the roxasistat: adding 150ml of toluene into a 500ml three-neck flask, and starting stirring; then 25g of compound (I), 17.97g of glycine are added; 42.27g of DBU are added dropwise at a temperature below 45 ℃; and (4) starting to heat to 80-85 ℃, keeping the temperature and reacting for 3h, and monitoring the reaction end point by TLC. After the reaction is finished, cooling to 30-40 ℃, then stirring for 15min with 150ml of water. Separating, discarding the toluene phase, washing the water phase with 100ml ethyl acetate once again, and separating the water phase; 19.17g of glacial acetic acid is quickly added into the water phase under stirring, the pH value is adjusted to be 4, a solid is separated out, and the stirring is continued for 2 h; filtering, washing a filter cake with purified water until the pH value is approximately equal to 6, and draining; transferring the filter cake to a vacuum drying oven, and vacuum drying at 55-60 ℃ for 12h to obtain crude product (II) (purity: 99.7%; yield: 95%).

Claims (10)

1. A method for synthesizing crude product of Rosemastat is characterized in that,
Figure FDA0002691950980000011
and reacting the compound (I) with glycine by taking DBU as alkali and toluene as a reaction solvent to obtain a target product, namely the crude product (II) of the roxasistat.
2. The synthesis process according to claim 1, characterized in that DBU is used in a molar amount of 2.0 to 5.0 times, preferably 3.0 times, that of compound (I).
3. The synthesis method according to claim 1, wherein the molar ratio of DBU to glycine reaction is: (0.8-1.2): 1, preferably 1: 1.
4. The synthesis process according to claim 1, wherein the amount of the reaction solvent is 4 to 7ml/g, preferably 6ml/g, of the compound (I).
5. The synthesis process according to claim 1, characterized in that the reaction temperature is between 25 ℃ and 100 ℃, preferably between 80 ℃ and 85 ℃.
6. The synthesis process according to claim 1, characterized in that the reaction time is 1 to 5 hours, preferably 3 hours.
7. The synthesis method according to claim 1, wherein after the reaction is completed, the crude product (II) of the target product, namely the Rosemastat, is obtained through cooling, water addition, liquid separation, washing, acid adjustment, pulping, filtering and drying.
8. The synthesis method according to claim 7, wherein after the reaction is completed, the temperature is reduced to 35-40 ℃, water is added for dissolution, liquid separation is carried out, and ethyl acetate is used for washing the water phase for 1-3 times.
9. The synthesis process according to claim 8, wherein the aqueous phase is adjusted to a pH of 3.8 to 4.2, preferably 4, with glacial acetic acid.
10. The synthesis method according to claim 9, wherein the acid is adjusted to separate out a solid, the solid is pulped at room temperature for 1.5-2.5 h and then filtered, and the filter cake is washed by purified water until the pH value is 5.8-6.2, and vacuum drying is carried out at 55-60 ℃ for more than 12h, so as to obtain the crude product of the roxasistat.
CN202010994236.7A 2020-09-21 2020-09-21 Synthesis method of Rosxastat Pending CN114249690A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010994236.7A CN114249690A (en) 2020-09-21 2020-09-21 Synthesis method of Rosxastat

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010994236.7A CN114249690A (en) 2020-09-21 2020-09-21 Synthesis method of Rosxastat

Publications (1)

Publication Number Publication Date
CN114249690A true CN114249690A (en) 2022-03-29

Family

ID=80788244

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010994236.7A Pending CN114249690A (en) 2020-09-21 2020-09-21 Synthesis method of Rosxastat

Country Status (1)

Country Link
CN (1) CN114249690A (en)

Similar Documents

Publication Publication Date Title
CN108658858B (en) Preparation and refining method of hydroxychloroquine and preparation method of sulfate thereof
JP4892915B2 (en) Epalrestat manufacturing method
CN112645875A (en) Preparation method of procaterol hydrochloride impurity
CN110511159B (en) Synthesis method of benserazide hydrochloride
CN111848505B (en) Vardutasteride Process for the preparation of intermediates
CN114249690A (en) Synthesis method of Rosxastat
CN111533710A (en) Method for preparing cefotiam intermediate 2-aminothiazole-4-acetic acid by one-pot method
WO2020048963A1 (en) Process for the preparation of lenvatinib
CN107522718B (en) A kind of synthetic method of Marbofloxacin
CN111253272B (en) Method for preparing benzamide compound
CN109232427A (en) A kind of preparation method of Edaravone
CN111100042B (en) Preparation method of 2-methoxy-5-sulfonamide benzoic acid
CN104098509B (en) A kind of method for preparing A type atazanavir sulfate
CN100457714C (en) Preparing and separating purifying method for 3,4'-diamino diphenyl ether
CN107382898B (en) Energetic material based on ANPZ energetic parent structure and synthetic method thereof
CN108976140B (en) Preparation method and intermediate of 2-amino-6-ethylbenzoic acid
CN101704778B (en) Method for preparing 4-hydroxyl yrrolidone-2-acetamide
CN114181152B (en) Preparation method of arylpyrazole drug intermediate
CN113045491B (en) Preparation method of lenvatinib and intermediate
CN115636765B (en) Synthesis method of N-hydroxymethyl benzamide
CN114213261B (en) Preparation method of 4-methoxy-2-nitroaniline
CN110372594B (en) Synthesis method of 1, 3-dimethyl-1H-pyrazole-4-formic acid
CN105732524A (en) A preparing method of 6-bromo-3-hydroxy-2-pyrazinamide
CN113045446A (en) Preparation method of transpeptidase biochemical test reagent substrate
CN115894245A (en) Preparation method of nitrosobenzene derivative

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20220329